Akèy › Kansè pwostat › Distrik Columbia
Etid klinik pou Kansè pwostat nan Distrik Columbia
18 etid pou Kansè pwostat ap chèche patisipan nan sit nan Distrik Columbia.
Vil nan Distrik Columbia
Tèks ofisyèl etid la (Anglè)
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Oct 2, 2026 · NCT06931340Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 40 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT05334069Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- MedStar Georgetown University Hospital, Washington D.C.
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT03866382A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
- MedStar Washington Hospital Center ( Site 0103), Washington D.C.
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06136650Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
- Washington DC VA Medical Center, Washington, DC, Washington D.C.
Ap rekriteFaz 2
Laj 18 ak plis · Gason · Mizajou Sep 17, 2026 · NCT04038502A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
- The GW Medical Faculty Associates ( Site 0057), Washington D.C.
- Washington DC Veterans Affairs Medical Center ( Site 0056), Washington D.C.
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Sep 17, 2026 · NCT06925737Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- George Washington University Medical Center, Washington D.C.
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Sep 10, 2026 · NCT05946213MRI-based Focal Intraprostatic Simultaneous Integrated Boost (SIB) Intensification With De-escalated Adaptive-risk SBRT for Patients With Low to Intermediate Risk Prostate Cancer
- Lombardi Comprehensive Cancer Center, Georgetown University, Washington D.C.
Ap rekriteFaz 2
Laj 18 ak plis · Gason · Mizajou Aug 20, 2026 · NCT07644598Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- Sibley Memorial Hospital, Washington D.C.
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Aug 19, 2026 · NCT04423211FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Johns Hopkins University, Sibley Memorial Hospital, Washington D.C.
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT05919264Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- Sibley Memorial Hospital, Washington D.C.
- George Washington University Medical Center, Washington D.C.
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Jul 14, 2026 · NCT06592924Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
- VA Medical Center, Washington D.C.
Ap rekriteFaz 4
Laj 18 a 100 · Gason · Mizajou Jun 4, 2026 · NCT05803941Cancer Experience Registry (CER) for Cancer Patients and Caregivers
- Cancer Support Community Research & Training Institute, Washington D.C.
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Apr 23, 2026 · NCT02333604Clinical Trial of Approaches to Prostate Cancer Surgery
- Georgetown University, Washington D.C.
Ap rekrite
Laj 40 a 80 · Gason · Mizajou Apr 22, 2026 · NCT05155501Castrate Resistant Prostate Cancer Enhertu Therapy
- Washington DC VAMC, Washington D.C.
Ap rekriteFaz 2
Laj 18 ak plis · Gason · Mizajou Apr 13, 2026 · NCT06610825Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
- Washington DC VA Medical Center, Washington, DC, Washington D.C.
Ap rekriteFaz 2/3
Laj 18 ak plis · Gason · Mizajou Apr 8, 2026 · NCT04787744Polygenic Risk Stratification Combined With mpMRI to Identify Clinically Relevant Prostate Cancer
- Howard University Hospital, Washington D.C.
Ap rekriteVolontè an sante akeyi
Laj 40 a 69 · Gason · Mizajou Nov 10, 2025 · NCT06398639Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
- George Washington University Medical Center, Washington D.C.
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Sep 11, 2025 · NCT03678025Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.